• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Drug-Device Combinations

New CEO for Orthofix, COO out at Echo Therapeutics | Personnel Moves

June 16, 2011 By drugdelivery

Orthofix
Echo Therapeutics

Orthofix International (NSDQ:OFIX) and Echo Therapeutics (OTC:ECTE) are both looking for new operations chiefs, but for different reasons.

Filed Under: Drug-Device Combinations Tagged With: Echo Therapeutics Inc., Orthofix International, Personnel

Parkinson's Disease: Could Medtronic pact with Lilly lead to a cure?

April 27, 2011 By drugdelivery

Medtronic

The collaboration between Eli Lilly & Co. (NYSE:LLY) and Medtronic Inc. (NYSE:MDT) could some day slow, or even cure, Parkinson’s disease, according to the Minneapolis, Minn.-based company’s top doc.

Filed Under: Drug-Device Combinations Tagged With: Amgen, Eli Lilly & Co., Parkinson's disease

Parkinson's disease: Medtronic and Eli Lilly team up on new drug delivery treatment

April 26, 2011 By drugdelivery

Medtronic

Medtronic Inc. (NYSE:MDT) is looking to bolster its position in the Parkinson’s disease market via a collaboration with Eli Lilly & Co. (NYSE:LLY) to develop a system to deliver drug therapies directly to the brain.

Filed Under: Drug-Device Combinations Tagged With: Eli Lilly & Co., Parkinson's disease

Medtronic bankrolls drug-device trial for Nile Therapeutics heart failure treatment

March 1, 2011 By drugdelivery

Medtronic

Medtronic Inc. (NYSE:MDT) will fund a clinical trial for Nile Therapeutics Inc. (NSDQ:NLTX) behind a peptide treatment for heart failure.

Filed Under: Drug-Device Combinations Tagged With: Nile Therapeutics

pSivida and TechniScan drum up $10 million in private rounds

January 19, 2011 By drugdelivery

Funding roundup logo

pSivida Corp. (NSDQ:PSDV) and TechniScan Inc. (OTC:TSNI) evidently wanted some privacy in their latest efforts to raise cash.

Watertown, Mass.-based pSivida, which develops ophthalmic drug-delivery devices, expects to net $9.9 million from an equity and warrant-based round involving a group of private investors, the company said today.

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: Breast Cancer, pSivida Corp., TechniScan Inc.

Surmodics accomodates Ramius with two new board members

January 6, 2011 By drugdelivery

SRDX logo

SurModics Inc. (NSDQ:SRDX) named two board members put forth by its largest shareholder, New York-based investment firm Ramius LLC.

The Eden Prairie, Minn.-based company said it named Ramius managing director Jeffrey Smith and Wheatley Partners partner Dr. David Dantzker to the board effective immediately.

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: SurModics Inc.

FDA rejects Iluvien, pSivida-Alimera's drug-device eye treatment

January 3, 2011 By drugdelivery

PSDV, ALIM logos

pSivida Corp. (NSDQ:PSDV) partner Alimera Sciences Inc. (NSDQ:ALIM) received a rejection letter from the Food & Drug Administration for their drug-device combination Iluvien.

The two companies are developing the system to treat diabetic macular degeneration. The investigational drug delivery system is designed for sustained release of Iluvien with an intra-vitreal insert.

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: Alimera Sciences, Gift Bans, pSivida Corp.

Pulmatrix lands $5.7 million grant from Uncle Sam

December 14, 2010 By drugdelivery

Pulmatrix logo

Pulmatrix Inc. landed a $5.7 million contract from the Defense Advanced Research Projects Agency to develop a drug/device combination aimed at protecting military personnel and civilians against biological weapons.

DARPA selected the Lexington, Mass.-based company as part of its “7-day Biodefense Initiative,” a project to develop inhaled therapeutics for respiratory infections caused by airborne agents.

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: Pulmatrix Inc.

Nonprofit takes risk out of device development for Medtronic

November 15, 2010 By drugdelivery

MedCity News logo

For companies like Medtronic Inc. (NYSE:MDT), developing breakthrough technologies to treat untreatable diseases can be expensive and have little promise of financial returns.

The risk is high enough for — even companies as well-resourced as Fridley, Minn.-based Medtronic — that alternative funding sources are welcomed and highly sought after.

Filed Under: Business/Financial News, Discovery, Drug-Device Combinations, Research & Development

pSivida's Q4 sales jump 388 percent

September 23, 2010 By drugdelivery

PSDV logo

pSivida Corp. (NSDQ:PSDV) sailed into the black with a 388 percent increase in revenues during the fourth quarter of fiscal 2010.

The Watertown, Mass.-based ophthalmic drug-delivery device maker posted net earnings of $13.1 million, or 68 cents per diluted share, on sales of $15.7 million during the three months ended June 30. That compares with a net loss of $534,000, or 3 cents per diluted share, on sales of $3.2 million during the same period last year.

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: pSivida Corp.

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 184
  • Go to page 185
  • Go to page 186
  • Go to page 187
  • Go to page 188
  • Go to page 189
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS